TrialBreast cancer research and treatment2012

Incremental increase in VEGFR1⁺ hematopoietic progenitor cells and VEGFR2⁺ endothelial progenitor cells predicts relapse and lack of tumor response in breast cancer patients.

Sarika Jain et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.